GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tenet Healthcare Corp (NYSE:THC) » Definitions » Cash Conversion Cycle

Tenet Healthcare (Tenet Healthcare) Cash Conversion Cycle : -38.24 (As of Dec. 2023)


View and export this data going back to 1976. Start your Free Trial

What is Tenet Healthcare Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Tenet Healthcare's Days Sales Outstanding for the three months ended in Dec. 2023 was 49.29.
Tenet Healthcare's Days Inventory for the three months ended in Dec. 2023 was 40.38.
Tenet Healthcare's Days Payable for the three months ended in Dec. 2023 was 127.91.
Therefore, Tenet Healthcare's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was -38.24.


Tenet Healthcare Cash Conversion Cycle Historical Data

The historical data trend for Tenet Healthcare's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenet Healthcare Cash Conversion Cycle Chart

Tenet Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only -54.50 -49.85 -45.10 -57.98 -54.53

Tenet Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.44 -43.53 -31.27 -32.52 -38.24

Competitive Comparison of Tenet Healthcare's Cash Conversion Cycle

For the Medical Care Facilities subindustry, Tenet Healthcare's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenet Healthcare's Cash Conversion Cycle Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Tenet Healthcare's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Tenet Healthcare's Cash Conversion Cycle falls into.



Tenet Healthcare Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Tenet Healthcare's Cash Conversion Cycle for the fiscal year that ended in Dec. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=52.02+41.48-148.03
=-54.53

Tenet Healthcare's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=49.29+40.38-127.91
=-38.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tenet Healthcare  (NYSE:THC) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Tenet Healthcare Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Tenet Healthcare's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenet Healthcare (Tenet Healthcare) Business Description

Traded in Other Exchanges
Address
14201 Dallas Parkway, Dallas, TX, USA, 75254
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of June 2023) and over 550 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Executives
Richard W Fisher director
Roy Blunt director 2702 LOVE FIELD DRIVE, HDQ 4GC, DALLAS TX 75235
Paola M Arbour officer: EVP, Chief Information Officer 14201 DALLAS PARKWAY, DALLAS TX 75254
Stephen H Rusckowski director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Thomas W Arnst officer: EVP, Chief Admin. Officer & GC 14201 DALLAS PARKWAY, DALLAS TX 75254
Tammy Romo director C/O SOUTHWEST AIRINES CO., 2702 LOVE FIELD DR., DALLAS TX 75235
Daniel J Cancelmi officer: Principal Accounting Officer 13737 NOEL ROAD, SUITE 100, DALLAS TX 75240
J Robert Kerrey director NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Richard J Mark director 1901 CHOUTEAU AVENUE MC-1310, ST. LOUIS MO 63103
Ronald A Rittenmeyer director 5400 LEGACY DRIVE, PLANO TX 75024
Lisa Y Foo officer: EVP, Commercial Ops 14201 DALLAS PARKWAY, DALLAS TX 75254
Audrey T. Andrews officer: SVP and General Counsel 1445 ROSS AVENUE, SUITE 1400, DALLAS TX 75202
Meghan Fitzgerald director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Howard Hacker officer: EVP, Chief Compliance Officer 14201 DALLAS PARKWAY, DALLAS TX 75254
Marie Quintana officer: EVP, Marketing/Communications 14201 DALLAS PARKWAY, DALLAS TX 75254